Mira Ludwikowska is a Chief Specialist at the Agency for Health Technology Assessment and Tariff System (AOTMiT) in Poland and Co-Chair of the Joint Scientific Consultation (JSC) Subgroup. She specializes in health technology assessment, with expertise in the evaluation of clinical and economic evidence for pharmaceuticals and their use in reimbursement and policy decision-making. At the European level, she contributes to Joint Scientific Consultations as an assessor, co-assessor, and Co-Chair, supporting collaboration among HTA bodies and the implementation of the EU HTA Regulation. Her work is driven by a commitment to evidence-informed healthcare decision-making and effective international cooperation in HTA.